China, India, Russia, South Africa TB Cases Spur International Coalition
This article was originally published in PharmAsia News
The growth of a drug-resistant version of tuberculosis in China, India, Russia and South Africa has spurred an international coalition of scientists to focus on a vaccine to block its spread as part of a comprehensive effort.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.